ArticleClinical and translational science2023

Preclinical assessment of drug-drug interaction of fb-PMT, a novel anti-cancer thyrointegrin αvβ3 antagonist.

Kazutoshi Fujioka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.